timothy sykes logo
Colgate-Palmolive Partners With WHO Foundation to Tackle Global Oral Health Thumbnail
G Google News

Colgate-Palmolive Partners With WHO Foundation to Tackle Global Oral Health

JACK KELLOGG•UPDATED JUN. 15, 2026, 4:34 PM ET
Reviewed by Tim Sykesand Fact-checked by Ellis Hobbs

Colgate-Palmolive Company’s stocks have been trading up by 5.92 percent amid positive sentiment from promising product innovations.

Key Highlights

  • The partnership with the WHO Foundation aims to enhance global oral health by integrating oral care into national health systems and reaching 2 billion children worldwide.
  • Price targets for Colgate-Palmolive have been raised by various financial institutions; JPMorgan and BNP Paribas Exane lifted the target to $93, maintaining an Overweight rating.
  • RBC Capital Markets projects a robust performance for Colgate-Palmolive, highlighting strong international business momentum and a supportive foreign exchange tailwind as key strengths.
  • Barclays adjusted Colgate-Palmolive’s price target amidst concerns about possible oil, currency headwinds, and fundamental challenges in 2026, yet they still maintain an Equal Weight rating.
  • Deutsche Bank noted an average rating of Overweight with its recent target adjustment, affirming a Hold stance and reflecting some market caution.

Consumer Staples industry expert:

Analyst sentiment – positive

Colgate-Palmolive (CL) is currently displaying robust financial health, evidenced by its superior profitability ratios such as an EBIT margin of 22.1% and a gross margin of 60.2%, indicating strong operational efficiency. With a return on equity (ROE) at a staggering 479.2%, the company demonstrates exceptional management effectiveness, bolstered by its high asset turnover rate of 1.2. Its revenue growth is consistent at a CAGR of 4.24% over three years, supported by a stable revenue-per-share figure. However, a notable concern is its high price-to-book ratio of 80.04, suggesting potential overvaluation. While Colgate’s total debt-to-equity is significantly high at 9.84, the interest coverage of 10.2 indicates manageable debt servicing capability. Overall, Colgate’s robust profitability and capital efficiency outweigh its leverage concerns, positioning it favorably within the Consumer Staples sector.

Technical analysis of CL reveals a neutral-to-bullish short-term price movement. Despite a brief pullback to $84.7, the subsequent sharp rise to $90.29, coupled with substantial closing strength, indicates strong upward momentum. The volume patterns support this with an apparent increase during the price rise, suggesting robust institutional support. A clear actionable strategy would be to enter a long position upon a sustained break and close above the key resistance at $90, with a stop-loss placed slightly below $88 to manage downside risk. Investors should monitor closely for confirmation of trend continuation, which could offer further upside potential.

Colgate-Palmolive’s strategic partnership with the WHO Foundation reflects its commitment to global health initiatives, likely strengthening its brand equity. The positive sentiment from major financial institutions, such as JPMorgan and BNP Paribas, which have raised their price targets to $93, aligns with Colgate’s strong performance and innovative capabilities within its industry. Despite potential headwinds from currency fluctuations and volatile input costs, the consensus remains optimistic with an average price target above the current trading levels. Colgate retains a key competitive advantage within the broader Consumer Staples market through its strategic initiatives and strong financial posture. Given these factors, I maintain a positive outlook on CL, anticipating continued resilience and growth in line with analyst expectations.

Candlestick Chart

More Breaking News

Weekly Update Jan 26 – Jan 30, 2026: On Friday, January 30, 2026 Colgate-Palmolive Company stock [NYSE: CL] is trending up by 5.92%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

Colgate-Palmolive has delivered some promising financial metrics recently, with notable growth in revenue and profitability margins. In the recent trading sessions, CL showed strong performance as its price closed at $90.29, reflecting a rising trend. The stock’s price targets have been lifted by multiple analysts, amid the overarching optimism regarding innovative product offerings and strategic market positioning.

The company has exhibited robust financial health with a gross margin of 60.2% and a profit margin reaching upwards of 15%. This standing is underpinned by their strong turnover rates and efficient cost management strategies. Financial strengths include a disciplined approach to leverage, and excellent management effectiveness, evidenced by high return on equity ratios exceeding 450%.

Conclusion

Colgate-Palmolive is on a progressively upward trajectory given its recent strategic moves and favorable analyst recommendations. The company’s dedication to innovating and its aggressive global expansion plans resonate well with the market. However, it’s crucial for traders to remain cautious and not be swept up by the excitement. As millionaire penny stock trader and teacher Tim Sykes says, “There is always another play around the corner; don’t chase just because you feel FOMO.” Despite some perceived external risks, CL appears well-positioned to maintain its price momentum in the near future, supported by its strong financial structure and effective management strategies.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”